Comment on: “Impact of Serum Albumin Levels on FDG Uptake in the Liver, Spleen, and Bone Marrow During Gastrointestinal Cancer Staging: A PET-CT Study”
Abstract views: 15
/ 
PDF downloads: 2
DOI:
https://doi.org/10.5281/zenodo.14775959Keywords:
Not AvailableAbstract
Letter to Editor
References
Çetinkaya E, Tuzcu ŞA. Impact of Serum Albumin Levels on FDG Uptake in the Liver, Spleen, and Bone Marrow During Gastrointestinal Cancer Staging: A PET-CT Study: FDG PET-CT Uptake in GIS Cancers. J Eur Int Med Prof. 2024;2(4):124-129.
Li WI, Ng K, Wong W, Ng K, Yong T, Kung B. Serum Albumin Alters [18F]FDG Activity in the Liver and Blood Pool. World Journal of Nuclear Medicine. 2024. doi: 10.1055/s-0044-1795100.
Wang CY, Hsieh MJ, Chiu YC, et al. Higher serum C-reactive protein concentration and hypoalbuminemia are poor prognostic indicators in patients with esophageal cancer undergoing radiotherapy. Radiother Oncol. 2009;92(2):270-275. doi:10.1016/j.radonc.2009.01.002
Boonpipattanapong T, Chewatanakornkul S. Preoperative carcinoembryonic antigen and albumin in predicting survival in patients with colon and rectal carcinomas. J Clin Gastroenterol. 2006;40(7):592-595. doi:10.1097/00004836-200608000-00006
Alici S, Kaya S, Izmirli M, et al. Analysis of survival factors in patients with advanced-stage gastric adenocarcinoma. Med Sci Monit. 2006;12(5):CR221-CR229.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2025 Bediz Kurt İnci
This work is licensed under a Creative Commons Attribution 4.0 International License.
The journal is licensed under a 